Progressive Mobility: Red & Yellow Flags for Cardiac Patients

Domain 🚫 Red Flags (Stop Mobility) ⚠️ Yellow Flags (Proceed with Caution)
Ischemia / ACS Active chest pain/angina not relieved by rest or meds
ST changes during activity
Troponin rising + unstable hemodynamics
New ACS < 24–48 hrs (unless cleared)
Stable angina controlled with meds
Recent ACS > 48–72 hrs and cleared
Mild chest tightness w/o ECG changes (monitor)
Blood Pressure SBP < 90 or > 180 mmHg
MAP < 65 or > 110
Symptomatic orthostatic drop > 20 mmHg
SBP 160–180 mmHg but stable
MAP 65–70 with stable symptoms
Orthostatic drop 10–20 mmHg with mild dizziness
Heart Rate / Rhythm HR < 40 or > 130 bpm at rest
Uncontrolled arrhythmias (VT/VF, AFib RVR > 130 bpm)
New heart block with symptoms
Frequent VT runs (> 3 beats)
Stable AFib/flutter HR < 130
Frequent PVCs > 6/min but stable
HR 110–130 bpm if asymptomatic
Controlled tachy/brady rhythms with stable BP
Oxygenation SpO₂ < 88% despite O₂
Desaturation > 5% with minimal activity
Severe pulmonary edema with rest dyspnea
SpO₂ 88–90% on O₂ and stable
Mild desaturation ≤ 4% but recovers quickly
Dyspnea on exertion that resolves with rest
Heart Failure Acute decompensated HF with pulmonary edema
Orthopnea at rest
On inotropes/vasopressors for perfusion
Stable on diuresis with mild dyspnea
Mild edema, stable O₂ needs
Recently weaned from inotropes (monitor closely)
Post-Op / Procedure Fresh sternotomy with unstable vitals
Uncontrolled bleeding at cath/graft site
Unstable chest tube drainage
Post-CABG day 1–2 if stable, pain controlled
Recent pacemaker/ICD (observe precautions)
Mild sternal discomfort with stable incision

🚫 Red Flags: Absolute contraindications to mobility — defer activity, notify team.
⚠️ Yellow Flags: Relative concerns — proceed with modifications, monitor vitals closely.
Green Light: Stable vitals, controlled arrhythmias, no ischemia — full progressive mobility.

References

  1. AHA/ACC. 2021 Chest Pain Guidelines. Circulation. 2021.
  2. AHA/ACC/HRS. 2019 AFib Update. JACC. 2019.
  3. APTA Acute Care Section. Vital Signs & Lab Values Guide. 2022.
  4. SCCM. ICU Early Mobility Guidelines. Crit Care Med. 2017.
  5. Hodgson CL, et al. Early mobilization safety. Crit Care. 2014;18(6):658.

Cardiac-Related Presentations in the Emergency Department

Cardiac complaints are among the most common and high-risk reasons for ED visits. A systematic approach—reason for visit, symptoms, vital signs, screening, diagnostics, pathophysiology, and disposition—ensures rapid recognition and appropriate triage of life-threatening conditions.1–8

1. Reasons for Visit

  • Chest pain (ischemia, aortic dissection, pericarditis, musculoskeletal pain)1–2
  • Shortness of breath (heart failure, arrhythmia, pulmonary embolism)3,5
  • Palpitations (arrhythmias, stimulant use, anxiety)4
  • Syncope or near-syncope (arrhythmia, structural heart disease, vasovagal)4
  • Fatigue/weakness (low-output heart failure, anemia)3
  • Peripheral edema/weight gain (volume overload from HF or valvular disease)3,7

2. Symptoms

Primary ComplaintAssociated Symptoms
Chest PainPressure, heaviness, radiation (jaw, arm, back), diaphoresis, nausea1–2
DyspneaOrthopnea, paroxysmal nocturnal dyspnea, cough, wheeze3
PalpitationsRapid/irregular heartbeat, dizziness, anxiety4
SyncopeSudden LOC, prodrome of diaphoresis or nausea4
FatigueExercise intolerance, generalized weakness3
EdemaLeg swelling, ascites, abdominal fullness3,7

3. Vital Signs

  • Blood Pressure (BP): Hypertension in ACS/dissection; hypotension in shock or tamponade.1–3,6,8
  • Heart Rate (HR): Tachycardia in sympathetic drive, HF, PE; bradycardia in AV block/inferior MI.2–4,6
  • Respiratory Rate (RR): Tachypnea in PE or pulmonary edema.3,5
  • Oxygen Saturation (SpO₂): Hypoxemia in HF, PE, ACS with pulmonary edema.2–3,5
  • Temperature: Fever in myocarditis, endocarditis, or PE.5–7

4. Screening Tests

  • ECG (within 10 minutes for chest pain)1–2
  • Troponin, CK-MB1–2
  • BNP/NT-proBNP for suspected HF3
  • CBC, CMP, glucose
  • Chest X-ray (cardiomegaly, pulmonary edema, dissection signs)3,8
  • POCUS (LV function, pericardial effusion, IVC)3,6

5. Diagnostic Pathways with Vital Signs

ConditionDiagnosticsVital Sign Fluctuations
ACS1–2 Serial troponins, ECG evolution, angiography BP: High → low in shock; HR: tachy or brady (AV block); SpO₂: falls with pulmonary edema
Heart Failure3 BNP/NT-proBNP, echocardiogram, CXR BP: high early → low in shock; HR: tachy/arrhythmias; SpO₂: reduced; RR: tachypnea
Arrhythmias4 Telemetry, Holter, EP study BP: unstable with poor CO; HR: tachy or profound brady; SpO₂: variable
PE5 D-dimer → CTPA BP: hypotension in massive PE; HR: tachycardia; SpO₂: severe hypoxemia; RR: tachypnea; Temp: low-grade fever
Valvular Disease7 Echocardiography (TTE/TEE), MRI BP: narrow (AS), wide (AR); HR: tachy in decomp; SpO₂: low with congestion
Pericarditis/Tamponade6 ECG, echocardiogram, CRP/ESR BP: hypotension, pulsus paradoxus; HR: tachycardia; SpO₂: reduced
Aortic Dissection8 CT angiography, TEE, MRI BP: severe HTN → hypotension if rupture; HR: reflex tachycardia; SpO₂: low with malperfusion

6. Pathophysiology, Etiology, and Disposition

Acute Coronary Syndrome (ACS)1–2

Etiology: Atherosclerotic plaque rupture, coronary thrombosis, vasospasm.

Risks: Hypertension, diabetes, dyslipidemia, smoking, family history.

Age Spectrum: Rare in pediatrics; common after 40, especially >55 (men) and >65 (women).

Pathophysiology: Plaque rupture exposes subendothelial collagen, initiating platelet aggregation and thrombus formation. Coronary occlusion reduces oxygen delivery to the myocardium, producing ischemia that progresses to necrosis if not reversed. Ischemia triggers sympathetic activation (↑BP, ↑HR); as infarction enlarges and contractility falls, cardiogenic shock develops with hypotension, pulmonary edema, and hypoxemia.

Disposition: Telemetry for stable NSTEMI/angina; ICU for STEMI, shock, or malignant arrhythmias.

Heart Failure (HF)3

Etiology: Ischemic cardiomyopathy, long-standing HTN, valvular disease, myocarditis, chemotherapy toxicity.

Risks: CKD, diabetes, obesity, alcohol, aging.

Age Spectrum: Rare in youth (except myocarditis); highly prevalent in older adults.

Pathophysiology: Ventricular systolic/diastolic dysfunction lowers stroke volume and cardiac output. RAAS and sympathetic activation attempt to maintain perfusion but raise afterload and drive sodium/water retention, elevating filling pressures and causing pulmonary congestion/systemic edema. Early hypertension and tachycardia give way to hypotension, tachypnea, and hypoxemia as alveolar flooding progresses.

Disposition: Telemetry after stabilization with diuresis and oxygen; ICU for shock, severe pulmonary edema (BiPAP/intubation), or inotrope/mechanical support.

Arrhythmias (SVT, AFib, VT, Bradyarrhythmias)4

Etiology: CAD, structural remodeling, electrolyte/thyroid imbalance, drug toxicity, congenital conduction disease.

Risks: Hypertension, obstructive sleep apnea, stimulant use, older age, family history of sudden death.

Age Spectrum: SVT in young adults; AFib increases >65; bradyarrhythmias/VT more in elderly.

Pathophysiology: Re-entry circuits, ectopic foci, or conduction block disrupt synchronous contraction. Tachyarrhythmias shorten diastolic filling (↓preload, ↓CO) and may precipitate hypotension; ventricular arrhythmias can cause immediate collapse. Bradyarrhythmias lower heart rate and stroke volume, reducing cerebral perfusion (syncope) and oxygen delivery; SpO₂ varies with perfusion adequacy.

Disposition: Telemetry for controlled AFib/SVT; ICU for unstable VT/VF, high-grade AV block, or refractory AFib with RVR.

Pulmonary Embolism (PE)5

Etiology: Venous thromboembolism, hypercoagulable states, malignancy, pregnancy, immobility.

Risks: Surgery, trauma, OCP/HRT use, thrombophilia, cancer.

Age Spectrum: Rare in children; young adults with thrombophilia; common in older adults with comorbidities.

Pathophysiology: Pulmonary arterial obstruction acutely increases pulmonary vascular resistance, straining and dilating the RV. RV failure reduces LV preload and systemic CO. Ventilation–perfusion mismatch impairs oxygenation, causing hypoxemia and tachypnea; massive PE produces obstructive shock with hypotension and tachycardia.

Disposition: Telemetry for stable PE with mild O₂ needs; ICU for massive/submassive PE with shock, severe hypoxemia, RV failure, or need for thrombolysis/thrombectomy.

Pericarditis / Cardiac Tamponade6

Etiology: Viral infection, autoimmune disease, malignancy, renal failure, post-MI.

Risks: Cancer, uremia, connective tissue disease, trauma.

Age Spectrum: Viral pericarditis in younger adults; tamponade more common in older adults with malignancy/renal disease.

Pathophysiology: Pericardial inflammation leads to effusion; as volume rises, pericardial pressure exceeds diastolic ventricular pressures, restricting filling. Stroke volume and CO fall, causing hypotension, tachycardia, JVD, pulsus paradoxus, and systemic hypoperfusion; SpO₂ declines from inadequate oxygen delivery.

Disposition: Telemetry for uncomplicated pericarditis; ICU for tamponade with hemodynamic compromise (urgent drainage).

Valvular Disease (AS, AR, MR, MS)7

Etiology: Rheumatic fever, congenital lesions, calcific degeneration, infective endocarditis.

Risks: Rheumatic history, bicuspid aortic valve, older age, radiation, prior endocarditis.

Age Spectrum: Congenital in youth; rheumatic in middle age; calcific in elderly.

Pathophysiology: Stenosis imposes pressure overload (ventricular hypertrophy); regurgitation imposes volume overload (dilation). Progressive remodeling culminates in HF. Vital signs mirror lesion physiology: aortic stenosis narrows pulse pressure; aortic regurgitation widens pulse pressure; mitral disease predisposes to AFib and pulmonary edema with hypoxemia.

Disposition: Telemetry for stable chronic lesions; ICU for acute severe regurgitation/stenosis with pulmonary edema or shock (urgent intervention).

Aortic Dissection8

Etiology: Hypertension, Marfan/Ehlers-Danlos, bicuspid valve, trauma, cocaine, prior surgery.

Risks: Chronic HTN, connective tissue disorders, pregnancy, stimulant use, pre-existing aneurysm.

Age Spectrum: Younger with CTD; older with HTN/atherosclerosis.

Pathophysiology: An intimal tear permits blood to track into the media, creating a false lumen that can obstruct branch vessels (malperfusion) or rupture (tamponade). Early sympathetic surge produces severe hypertension and tachycardia; rupture precipitates hypotension, shock, and hypoxemia.

Disposition: Telemetry for stable Type B (medical management); ICU for Type A or unstable Type B (surgical/endovascular repair).

7. Quick Reference Table: ICU vs Telemetry Admission

ConditionTelemetry (Stable)ICU (Unstable / High Risk)
ACS Stable NSTEMI or angina with preserved BP, pain controlled STEMI, cardiogenic shock, hypotension, malignant arrhythmias
Heart Failure Acute decompensation responsive to diuresis, mild hypoxemia Shock, severe pulmonary edema needing BiPAP/intubation, inotropes or mechanical support
Arrhythmias AFib/flutter with controlled rate, SVT responsive to adenosine, stable VT Unstable VT/VF, complete heart block with syncope, refractory AFib with RVR, pacing/defibrillation
PE Subsegmental/segmental PE, stable vitals, O₂ < 4 L/min Massive/submassive PE with shock, severe hypoxemia, RV failure, thrombolysis/thrombectomy
Pericarditis/Tamponade Simple pericarditis or small stable effusion Tamponade with hypotension/pulsus paradoxus, urgent pericardiocentesis
Valvular Disease Chronic stable stenosis/regurgitation under monitoring Acute severe valve failure with pulmonary edema/shock, urgent surgery
Aortic Dissection Stable Type B dissection managed medically Type A or unstable Type B with rupture/shock, surgical or endovascular repair

References (AMA style)

  1. Gulati M, Levy PD, Mukherjee D, et al. 2021 AHA/ACC Guideline for the Evaluation and Diagnosis of Chest Pain. Circulation. 2021;144(22):e368-e454.
  2. Collet JP, Thiele H, Barbato E, et al. 2020 ESC Guidelines for the management of acute coronary syndromes. Eur Heart J. 2021;42(14):1289-1367.
  3. Ponikowski P, Voors AA, Anker SD, et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J. 2021;42(36):3599-3726.
  4. January CT, Wann LS, Calkins H, et al. 2019 AHA/ACC/HRS Focused Update on Atrial Fibrillation. J Am Coll Cardiol. 2019;74(1):104-132.
  5. Konstantinides SV, Meyer G, Becattini C, et al. 2019 ESC Guidelines on Pulmonary Embolism. Eur Heart J. 2020;41(4):543-603.
  6. Adler Y, Charron P, Imazio M, et al. 2015 ESC Guidelines for the diagnosis and management of pericardial diseases. Eur Heart J. 2015;36(42):2921-2964.
  7. Vahanian A, Beyersdorf F, Praz F, et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561-632.
  8. Erbel R, Aboyans V, Boileau C, et al. 2014 ESC Guidelines on the diagnosis and treatment of aortic diseases. Eur Heart J. 2014;35(41):2873-2926.